NEWS

Home >

Company News

Industry News

2025

Author:

Invitation| Sinoia 2025 Shanghai HNC Health and Nutrition Expo sincerely invites your presence - NEWGENBIO®, a global leader in enzyme supplements

2025 HNC Health and Nutrition Exhibition

Global leader in enzyme supplements
NEWGENBIO® -“Enzymes Supplement To The World

Focusing on core ingredients of digestive enzymes and probiotics,

Insight into functional food trends, exploring the boundaries of precision nutrition applications together.
Xinoyah sincerely invites you to visit the exhibition
Exchange and cooperation, create the future together!

June 24-26, 2025
National Convention and Exhibition Center (Shanghai)
★ Xinoyah Booth Number ★
Hall 2.1 21T10

★ Conference Speech ★

NEWGENBIO@High-activity Lactase

Speaker: Pan Weikang

Time: June 25, 2025, 11:00-12:00

Location: Mezzanine Conference Room M2-01, National Convention and Exhibition Center (Shanghai)

Xinoyah Xinoyah Xinoyah

—Product Introduction—

NEWGENBIO® Lactose The enzyme series products can provide products with different activity specifications according to application needs, with activity as high as 200,000 ALU/g (FCC VII test).

Starting from lactase, Xinoyah has built an enzyme preparation platform covering a variety of functional directions. Acidic DPP IV alleviates gluten allergy, serrapeptase is used in metabolic management and inflammation, and converting enzyme focuses on sucrose intolerance... We are concerned not only with "decomposition function", but also with the activation and connection of "health mechanisms".

Xinoyah's newly launched double-compartment probiotic series can keep probiotics fresh in real time. With the help of physical isolation compartments, it significantly improves the survival rate and ease of use of live bacteria. Combined with high-end strains (such as Akk bacteria, white ginseng bacteria, PDD-1, etc.), it empowers deeper applications from intestinal regulation and metabolic improvement to immune balance.

Xinoyah focuses on the R&D and industrialization of high-end functional probiotics. It has its own factories in China, the United States, and Germany, and has built a full industrial chain system covering raw materials, liquid drops, intelligent manufacturing, and global traceability. It can provide professional, efficient, and customized one-stop solutions for health products to brand owners and channel customers.

★ Xinoyah Booth Number ★
Hall 2.1 21T10

02/ About NEWGEN About Us

Ningbo Xinoyah Marine Biotechnology Co., Ltd. is located in Xiangshan County, Ningbo City. Established in 2013, it is a high-tech enterprise founded by Zhu Hui, an immunology expert who studied in the United States. Based on marine biological resources, the company uses synthetic biology technology to develop natural bioactive macromolecular products from marine organisms, aiming to provide intestinal nutritional health solutions and activate nutritional health services.

The company is at a high level in the world in the fields of marine polysaccharides, marine enzyme preparations, probiotics, and intestinal microecology. With its strong strength and advanced technology in the field of marine biomedicine, the company has undertaken a number of national, provincial, and municipal R&D projects, including the national "13th Five-Year Plan" marine innovation development and demonstration project, Ningbo's "2025 scientific and technological research" major project, and Ningbo's "bidding" major project.

The company has passed ISO22000:2015 food management system, ISO9001:2015 management system, HACCP food management system certification, Kosher, Halal and NSF-CGMP and other quality system certifications. It is a member of IPA (International Probiotics Association), ETA (Enzyme Technical Association) and other international associations, and has won many provincial and municipal technological innovation awards, including the third prize of the China Commercial Union Science and Technology Award, the second prize of the China Invention Association, and the third prize of the Ningbo Science and Technology Progress Award. The enterprise pays attention to intellectual property protection, and as of 2023, it has applied for more than 70 patents, and has been authorized 36 patents, including 23 invention patents.